- Safety & Recalls
- Regulatory Updates
- Drug Coverage
- COPD
- Cardiovascular
- Obstetrics-Gynecology & Women's Health
- Ophthalmology
- Clinical Pharmacology
- Pediatrics
- Urology
- Pharmacy
- Idiopathic Pulmonary Fibrosis
- Diabetes and Endocrinology
- Allergy, Immunology, and ENT
- Musculoskeletal/Rheumatology
- Respiratory
- Psychiatry and Behavioral Health
- Dermatology
- Oncology
Best Read Drug Coverage News in 2022
Drug coverage decisions and new offerings from OptumRx, Caremark, Cigna and Wellcare made the list of the top-read drug coverage news in 2022.
Cigna to Offer Three Stand-alone Medicare Drug Plans
Beginning in 2023, Cigna will offer three new Medicare supplemental Prescription Drug Plans (PDPs) in all 50 states, the District of Columbia and Puerto Rico. All plans have $0 copay options for select medications purchased through preferred home delivery. Additionally, Cigna will offer Medicare Advantage (MA) plans with enhanced features and benefits in 581 counties within 28 states.
OptumRx to Cover Amgen’s Biosimilar of Humira
Beginning in 2023, OptumRx plans to include on its formularies Amgen’s Amjevita, a biosimilar of AbbVie’s blockbuster rheumatoid arthritis drug Humira (adalimumab), as well as two additional biosimilars. The new biosimilars will be available on the Select and Premium formularies, according to a company spokesperson. No information has been provided on tiering or utilization management strategies that could be employed.
OptumRx Makes Utilization Management Changes for 2023
OptumRx has made a number of utilization management changes — requiring prior authorization or step therapy and putting quantity limits — on its formularies effective Jan. 1, 2023. The PBM now requires prior authorization for 16 products, including 11 that are used to treat patients with diabetes.
CVS Caremark Updates 2022 Formulary
CVS Caremark has released its Performance Drug List, Standard Control, for April 2022. Effective April 1, the company has removed 20 products from its Standard Control formulary when compared with the list effective from January 2021. CVS Caremark has also added several products, including some branded therapies.
Wellcare Expands Medicare Drug Coverage, Adds Amazon as Preferred Pharmacy
Beginning in January 2023, Wellcare will expand its range of Medicare Advantage and Medicare Prescription Drug Plan offerings. Its pharmacy offerings will be expanded to include 102 plans nationwide and will include $0 copays for COVID-19 vaccines and testing. Additionally, Amazon is now a preferred retail pharmacy. All plans will include a $0 tier 1 benefit when filled at preferred pharmacies, including Amazon, Walgreens, CVS, and most grocers.
Payers Recognize the Benefits, but Still See Weight Loss Drugs through a Cost Lens
April 12th 2024Jeffrey Casberg, M.S., R.Ph., a senior vice president of clinical pharmacy at IPD Analytics LLC, a drug intelligence firm that advises payers and pharmaceutical companies, talks about how payers are thinking about weight-loss drugs.
Humira Biosimilars Have a Slow Uptake, Finds Samsung Bioepis Report
April 8th 2024Caps on Medicare Part D cost sharing as a result of the Inflation Reduction Act, could reduce members’ financial incentive for switching to a biosimilar, suggests the newest Samsung Bioepis Quarterly Biosimilar Market Report.
